Advertisement

Topics

Benlysta Is Niche, But Growing, So GSK's Not Giving Up On Lupus

06:58 EDT 7 Aug 2017 | SCRIP

Sales of the BLyS inhibitor disappointed at launch, but the franchise is growing double-digits and now a new, more convenient...

      

Related Stories

 

Original Article: Benlysta Is Niche, But Growing, So GSK's Not Giving Up On Lupus

NEXT ARTICLE

More From BioPortfolio on "Benlysta Is Niche, But Growing, So GSK's Not Giving Up On Lupus"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...